Russell J. Cox
2013 - Jazz Pharmaceuticals
In 2013, Russell J. Cox earned a total compensation of $2.4M as Executive Vice President and Chief Operating Officer at Jazz Pharmaceuticals, a 40% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $380,000 |
---|---|
Option Awards | $765,325 |
Salary | $419,616 |
Stock Awards | $813,038 |
Other | $3,622 |
Total | $2,381,601 |
Cox received $813K in stock awards, accounting for 34% of the total pay in 2013.
Cox also received $380K in non-equity incentive plan, $765.3K in option awards, $419.6K in salary and $3.6K in other compensation.
Rankings
In 2013, Russell J. Cox's compensation ranked 3,281st out of 12,286 executives tracked by ExecPay. In other words, Cox earned more than 73.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,281 out of 12,286 | 73rd |
Division Manufacturing | 1,111 out of 4,612 | 76th |
Major group Chemicals And Allied Products | 291 out of 1,462 | 80th |
Industry group Drugs | 198 out of 1,156 | 83rd |
Industry Pharmaceutical Preparations | 165 out of 890 | 82nd |
Source: SEC filing on June 20, 2016.
Cox's colleagues
We found four more compensation records of executives who worked with Russell J. Cox at Jazz Pharmaceuticals in 2013.